We serve Chemical Name:S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate CAS:74345-73-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate
CAS.NO:74345-73-6
Synonyms:S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate
Molecular Formula:C6H9ClO2S
Molecular Weight:180.65200
HS Code:2930909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:229.078ºC at 760 mmHg
Density:1.224g/cm3
Index of Refraction:1.491
PSA:59.44000
Exact Mass:180.00100
LogP:1.66760
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate Use and application,S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate technical grade,usp/ep/jp grade.
Related News: From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate manufacturer Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate vendor Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. S-[(2R)-3-chloro-2-methyl-3-oxopropyl] ethanethioate factory The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market.